Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Paula, Arrabal Durán"'
Autor:
Patricia Hidalgo-Collazos, Cristina López González-Cobos, Paula Arrabal-Durán, María Sanjurjo-Sáez
Publikováno v:
Farmacia Hospitalaria, Vol 39, Iss 4, Pp 219-221 (2015)
Vancomycin is an antibiotic used for infections by gram-positive bacteria with a two-compartment pharmacokinetic model. Its monitoring has an established therapeutic range (10-20 mg/L) to prevent nephrotoxicity and ototoxicity due to supratherapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2b6ca28b272e75b73f3c35b067b6bbab
http://www.aulamedica.es/fh/pdf/8095.pdf
http://www.aulamedica.es/fh/pdf/8095.pdf
Autor:
Ana Herranz-Alonso, Carmen Guadalupe Rodríguez-González, Paula Arrabal-Durán, Paloma Gijón-Vidaurreta, Esther Chamorro-de-Vega, María Sanjurjo-Sáez
Publikováno v:
International journal of clinical practice. 71(8)
SummaryObjectives This study evaluates the effectiveness, safety and costs of switching to a rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF) regimen in treatment-experienced HIV-1-infected patients with sustained virological sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::721daa8e42e8e8a06b09a7920844c75a
https://pubmed.ncbi.nlm.nih.gov/28722790
https://pubmed.ncbi.nlm.nih.gov/28722790
Autor:
Silvia Buendía-Bravo, Eva González-Haba Peña, Raquel García-Sánchez, Paula Arrabal-Durán, María Norberta Sánchez-Fresneda, María Sanjurjo-Sáez
Publikováno v:
Farmacia Hospitalaria, Vol 39, Iss 6, Pp 333-337 (2015)
to assess the causes of the Emergency Department visits in cancer patients treated with antineoplastics. The secondary objective is to analyse the use of growth stimulating factors in febrile neutropenia.a retrospective observational study was conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af326b22e657f347985e58f3bcdb4e84
https://pubmed.ncbi.nlm.nih.gov/26618377
https://pubmed.ncbi.nlm.nih.gov/26618377
Autor:
Cristina Pascual-Izquierdo, María Sanjurjo-Sáez, Ana Herranz-Alonso, Esther Durán-García, Juan A. Andueza-Lillo, Paula Arrabal-Durán, Belén Marzal-Alfaro, Ana Castuera-Gil, Ana de Lorenzo-Pinto, Raquel García-Sánchez
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Objectives To evaluate the level of concordance between the 2007 PRETEMED guidelines and the 2012 American College of Chest Physicians (ACCP) guidelines in medical patients at admission. Methods A cross-sectional, observational and descriptive study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db1f4f913dc89ab7852a07fb25356568
https://pubmed.ncbi.nlm.nih.gov/31156835
https://pubmed.ncbi.nlm.nih.gov/31156835
Publikováno v:
Drugs & Therapy Perspectives. 32:447-448
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceede0461d9b4f0f333b7d4faacfa3aa
https://doi.org/10.1007/s40267-016-0324-3
https://doi.org/10.1007/s40267-016-0324-3
Autor:
Paula, Arrabal-Durán, M Esther, Durán-García, Almudena, Ribed-Sánchez, Patricia, Hidalgo-Collazos, María, Sanjurjo-Sáez
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 34(6)
Chronic Renal Failure (CRF) is a disease that requires determined medications dosages to be adjusted.To assess the characteristics of pharmaceutical interventions concerning the dose adjustment of these drugs in patients with CRF who are admitted int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2844626d4af9153d8e2f75f755c1d262
https://pubmed.ncbi.nlm.nih.gov/25415570
https://pubmed.ncbi.nlm.nih.gov/25415570
Autor:
Paula, Arrabal Durán, Rosa María, Romero Jiménez, Cristina, Cuerda Compes, Miguel, Camblor Álvarez, Irene, Bretón Lesmes, Ana, De Lorenzo Pinto, Silvia, Buendía Bravo, Laura, Frías Soriano, Pilar, García Peris, María, Sanjurjo Sáez
Publikováno v:
Nutricion hospitalaria. 29(5)
Home Parenteral Nutrition (HPN) is a practice in continually growing by the significant advantages involved for the patient and the healthcare system. Today, in the investigation of health outcomes is essential to assess the patient s opinion. Among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84c1d096700cfe5065cc04e6dacc5b08
https://pubmed.ncbi.nlm.nih.gov/24951994
https://pubmed.ncbi.nlm.nih.gov/24951994
Autor:
M Tovar Pozo, Vicente Escudero-Vilaplana, S Buendía-Bravo, Arantza Ais-Larisgoitia, M Sanjurjo Sáez, Paula Arrabal-Durán, Sara Ibáñez-García, A. Giménez Manzorro, CG Rodriguez-Gonzalez, Xandra García-González
Publikováno v:
European Journal of Hospital Pharmacy. 22:A94.2-A95
Background There are limited data that tackle safety and effectiveness of the triple treatment based on protease inhibitors (telaprevir or boceprevir) in liver transplant patients. Purpose To describe effectiveness and safety of the triple treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51d26a6c352168f6793b1c0cf7259575
https://doi.org/10.1136/ejhpharm-2015-000639.227
https://doi.org/10.1136/ejhpharm-2015-000639.227
Autor:
Xandra García-González, Paula Arrabal-Durán, María Sanjurjo-Sáez, Silvia Manrique-Rodríguez, Almudena Ribed, I Marquínez-Alonso, Cecilia M. Fernández-Llamazares, M Tovar-Pozo, S Buendía-Bravo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A94.1-A94
Background Ivabradine is authorised for the treatment of coronary artery disease and chronic heart failure with systolic dysfunction in adult patients, but there is little information on its efficacy and safety in children. Purpose To assess the use,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7690b4e8a3afc86009fcff8163522bf
https://doi.org/10.1136/ejhpharm-2013-000436.230
https://doi.org/10.1136/ejhpharm-2013-000436.230
Autor:
I Marquínez-Alonso, RM Romero-Jiménez, JM López-Gómez, A Vega-Martínez, CG Rodriguez-Gonzalez, Alvaro Gimenez-Manzorro, María Sanjurjo-Sáez, Paula Arrabal-Durán, Belén Marzal-Alfaro, Vicente Escudero-Vilaplana
Publikováno v:
European Journal of Hospital Pharmacy. 20:A98.2-A98
Background The use of erythropoiesis-stimulating agents (ESA) in the treatment of anaemia due to chronic kidney disease (CKD) is highly variable regarding patient characteristics and doses, including the equivalence among ESAs stated in the label pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56227e9145b524c79510713d373090b0
https://doi.org/10.1136/ejhpharm-2013-000276.275
https://doi.org/10.1136/ejhpharm-2013-000276.275